Minzhong Drop Renews China Overseas Listing Woes: Southeast Asia

Minzhong Drop Renews China Overseas Listing Woes: Southeast Asia

China Minzhong Food Corp. (MINZ) lost half its market value in less than two hours after short-seller Glaucus Research Group questioned the vegetable processor’s accounts, reviving investor concern about Chinese companies traded overseas. Glaucus said in a report the Putian, China-based company had been “significantly deceiving” regulators and investors, sending the stock 48 percent lower in Singapore trading yesterday and wiping S$318 million ($249 million) off its market value before it was suspended. Minzhong said it’s seeking legal opinion and will comment as soon as possible.Minzhong is the latest target of short sellers betting against Chinese companies trading in markets such as Hong Kong, Singapore and New York, even as five of the six analysts covering the stock recommend buying it. Minzhong is among the 143 China-based firms listed on Singapore’s S$967.4 billion stock market at the end of July, according to the exchange.

“The reputation of Chinese companies in Singapore has now rock-bottomed,” said Mou Hua Lee, Singapore-based analyst at CIMB Group Holdings Bhd. (CIMB) “With these new allegations, it’s going to be a very long while before anyone trusts Chinese companies here.”

Minzhong shares were halted at 53 Singapore cents, after tumbling the most since the company’s listing in April 2010. Short interest in the vegetable processor rose to a record 7.2 percent of the outstanding stock on Aug. 19 from this year’s low of 3.8 percent in March, according to the most recent data from research company Markit Group Ltd.

Fabricated Sales

Singapore Exchange Ltd. queried Minzhong on the share price decline and will continue to closely monitor developments, according to an e-mailed statement.

The company said late yesterday it’s reviewing the Glaucus report and will respond “shortly.” It’s also taking steps to defend its reputation and won’t hesitate to take legal action, it said in an e-mailed statement.

Minzhong may have fabricated sales and payments to its largest supplier, doctored historical accounts and overstated capital spending, Glaucus said in the report. It also questioned the food processor’s reported receivables and cash balance.

“Evidence indicates that Minzhong fabricated sales to its top two customers, suggesting that the Company overstated revenues in its IPO prospectus by at least a third during the track record period,” Glaucus said, citing corporate registry records.

Avoid S-chips

At least 29 Chinese firms on Singapore’s exchange, where one in five stocks are China-based companies, have been halted or ordered to delist since 2008. The FTSE ST China Index of 37 Chinese stocks traded in Singapore, commonly known as S-chips, has lost 14 percent in the past six months, more than twice the 5.2 percent slide in the benchmark Straits Times Index. (FSSTI)

“We typically avoid S-chips,” Daphne Roth, head of Asia equity research at ABN Amro Private Bank, which oversees about $207 billion, said from Singapore. “There is room for Chinese companies to improve corporate governance. That will help improve investor confidence.”

Minzhong’s biggest investor isn’t concerned. PT Indofood Sukses Makmur, the parent of Indonesia’s biggest instant-noodle maker and Minzhong’s largest shareholder, is comfortable with its investment, director Thomas Tjhie said yesterday by telephone from Jakarta.

Indofood, which doubled its stake in Minzhong to 29.3 percent in March, conducted due diligence on the company before it made its investment, Tjhie said, adding that he has spoken to Minzhong’s chief financial officer about the Glaucus report.

Response Needed

Minzhong needs to respond to the claims made by the Glaucus report, said Wei Bin, an analyst at Maybank Kim Eng Holdings Ltd. in Singapore.

“There’s still some value in the S-chips but we need to be conservative in ours views,” he said. “I don’t have enough facts to prove the report right or wrong at this point.”

Other companies that have been the focus of reports by Glaucus include China Metal Recycling Holdings Ltd. (773) and China Medical Technologies Inc. The short-seller claims to “help investors navigate treacherous financial waters in search of great investment opportunities,” according to its website.

Provisional liquidators were appointed to China Metal in July and its Hong Kong-traded stock has been suspended since January. China Medical filed for Chapter 15 foreign-firm bankruptcy protection in New York last year.

Olam Bets

The claims against Minzhong come less than a year after short-seller Carson Block said he was betting against Olam International Ltd. (OLAM), the Singapore-based commodity trader, sparking a slump in the stock. Block’s research firm Muddy Waters LLC later said Olam was likely to fail in a report. The commodity traded rejected the allegations.

Olam had recovered from the 7.5 percent slump after the report, rising as much as 9.2 percent as of May 22. Since the peak in the past year, the stock has dropped 20 percent, compared with the 5.7 percent decline in the MSCI AC Asia Pacific Commodity Producers index.

Muddy Waters has also targeted Chinese firms including Sino-Forest Corp., which plunged 74 percent before eventually filing for bankruptcy protection. Shares of New Oriental Education & Technology Group Inc. and Focus Media Holding Ltd., rebounded after initial slumps when Block questioned their accounting. Both companies have denied wrongdoing.

To contact the reporters on this story: Jonathan Burgos in Singapore at jburgos4@bloomberg.net; Michelle Yun in Hong Kong at myun11@bloomberg.net

Unknown's avatarAbout bambooinnovator
Kee Koon Boon (“KB”) is the co-founder and director of HERO Investment Management which provides specialized fund management and investment advisory services to the ARCHEA Asia HERO Innovators Fund (www.heroinnovator.com), the only Asian SMID-cap tech-focused fund in the industry. KB is an internationally featured investor rooted in the principles of value investing for over a decade as a fund manager and analyst in the Asian capital markets who started his career at a boutique hedge fund in Singapore where he was with the firm since 2002 and was also part of the core investment committee in significantly outperforming the index in the 10-year-plus-old flagship Asian fund. He was also the portfolio manager for Asia-Pacific equities at Korea’s largest mutual fund company. Prior to setting up the H.E.R.O. Innovators Fund, KB was the Chief Investment Officer & CEO of a Singapore Registered Fund Management Company (RFMC) where he is responsible for listed Asian equity investments. KB had taught accounting at the Singapore Management University (SMU) as a faculty member and also pioneered the 15-week course on Accounting Fraud in Asia as an official module at SMU. KB remains grateful and honored to be invited by Singapore’s financial regulator Monetary Authority of Singapore (MAS) to present to their top management team about implementing a world’s first fact-based forward-looking fraud detection framework to bring about benefits for the capital markets in Singapore and for the public and investment community. KB also served the community in sharing his insights in writing articles about value investing and corporate governance in the media that include Business Times, Straits Times, Jakarta Post, Manual of Ideas, Investopedia, TedXWallStreet. He had also presented in top investment, banking and finance conferences in America, Italy, Sydney, Cape Town, HK, China. He has trained CEOs, entrepreneurs, CFOs, management executives in business strategy & business model innovation in Singapore, HK and China.

Leave a comment